Benefit of Simulation-Based Training in Medical Adverse Events Disclosure in Pediatrics

Juliette Aubin1, Océane Rivolet1, Anne-Laure Taunay1

  • 1From the Pediatric Emergency Department.

Pediatric Emergency Care
|August 16, 2021
PubMed

Insights

Pediatric residents improved adverse event disclosure skills through simulation-based training and mastery learning. This training enhances communication, confidence, and knowledge, crucial for patient safety and trust.

Area of Science:

  • Medical Education
  • Patient Safety
  • Healthcare Communication

Background:

  • Adverse events (AEs) in healthcare represent a significant public health concern.
  • Effective disclosure of AEs is a critical yet challenging task for healthcare providers.

Purpose of the Study:

  • To evaluate the impact of simulation-based training on pediatric residents' performance in disclosing AEs to simulated parents.
  • To assess correlations between disclosure performance and demographic/experiential factors.
  • To measure knowledge gain and resident satisfaction with the training.

Main Methods:

  • Prospective study involving 49 pediatric residents undergoing two simulation sessions (SIM 1 and SIM 2) at a 3-week interval.
  • Intervention group received mastery learning training (didactic and role-playing) after SIM 1; control group received training after SIM 2.
  • Performance assessed by independent observers and simulated parents; knowledge evaluated via pre/post-tests.

Main Results:

  • The intervention group showed significant improvement in AE disclosure performance scores from SIM 1 to SIM 2 (P=0.02).
  • Simulated parents' subjective scores also increased significantly post-training (P<0.01).
  • Residents reported increased self-confidence (P=0.04) and knowledge gain (P=0.02), expressing satisfaction with the training.

Conclusions:

  • Simulation-based training coupled with mastery learning effectively enhances pediatric residents' ability to disclose adverse events.
  • Improved AE disclosure training is vital for maintaining family confidence in physicians and mitigating potential legal issues.
Abstract

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.2K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
56
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
207
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.5K
Types of Reports II: Incident or Occurrence Report01:21

Types of Reports II: Incident or Occurrence Report

An Incident or Occurrence Report in a healthcare setting is a crucial document used to record any unexpected occurrence that may or may not have affected a patient, employee, or visitor. Such reports are critical to improving patient safety and include all details leading up to and including the event.
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
979
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
5.1K